help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Winkler, K.
Right arrow Articles by Zahradnik, H. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Winkler, K.
Right arrow Articles by Zahradnik, H. P.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CHOLESTEROL
*ESTRADIOL
Medline Plus Health Information
*Pregnancy
The Journal of Clinical Endocrinology & Metabolism Vol. 85, No. 12 4543-4550
Copyright © 2000 by The Endocrine Society


Original Studies

Low Density Lipoprotein (LDL) Subfractions during Pregnancy: Accumulation of Buoyant LDL with Advancing Gestation

Karl Winkler, Birgit Wetzka, Michael M. Hoffmann, Isolde Friedrich, Martina Kinner, Manfred W. Baumstark, Heinrich Wieland, Winfried März and Hans Peter Zahradnik

Departments of Clinical Chemistry (K.W., M.M.H., I.F., H.W., W.M.), Obstetrics and Gynecology (B.W., M.K., H.P.Z.), and Sports Medicine (M.W.B.), University of Freiburg, D-79106 Freiburg, Germany

Address all correspondence and requests for reprints to: Karl Winkler, M.D., Department of Clinical Chemistry, Albert Ludwigs University School of Medicine, Hugstetter Strasse 55, D-79106 Freiburg, Germany. E-mail: kwinkler{at}ukl.uni-freiburg.de

Pregnancy is accompanied by changes in the maternal lipoprotein metabolism that may serve to satisfy the nutritional demands of the fetus. In this study lipoprotein metabolism was investigated in 23 women during normal pregnancy in the first, second, and third trimesters and in 15 healthy nonpregnant women with regular menstrual cycles. Lipid and apolipoprotein concentrations were measured in total plasma, very low density, intermediate density, low density (LDL), and high density lipoproteins, and in each of six LDL subfractions. During early pregnancy, triglycerides, and dense LDL were higher than in the nonpregnant state. With advancing gestation, triglycerides increased and the distribution of apolipoprotein B-100-containing lipoproteins became increasingly dominated by the accumulation of very low density and intermediate density lipoproteins and buoyant, triglyceride-rich LDL. This is the first study that investigates LDL subfractions in pregnancy using a method that strictly separates LDL subfractions by virtue of density. The accumulation of buoyant, triglyceride-rich lipoproteins may be related to the down-regulation of maternal lipase activities by placental hormones. As a consequence, the metabolic changes of late pregnancy may result in an increased flux of lipoprotein-derived lipids to the placenta, which, with advancing gestation, increasingly expresses receptors with a high affinity for triglyceride-rich lipoproteins.




This article has been cited by other articles:


Home page
PediatricsHome page
R. J. Edison, K. Berg, A. Remaley, R. Kelley, C. Rotimi, R. E. Stevenson, and M. Muenke
Adverse Birth Outcome Among Mothers With Low Serum Cholesterol
Pediatrics, October 1, 2007; 120(4): 723 - 733.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
C. Wadsack, S. Tabano, A. Maier, U. Hiden, G. Alvino, V. Cozzi, M. Huttinger, W. J. Schneider, U. Lang, I. Cetin, et al.
Intrauterine growth restriction is associated with alterations in placental lipoprotein receptors and maternal lipoprotein composition
Am J Physiol Endocrinol Metab, February 1, 2007; 292(2): E476 - E484.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
W. Marz, H. Scharnagl, K. Winkler, A. Tiran, M. Nauck, B. O. Boehm, and B. R. Winkelmann
Low-Density Lipoprotein Triglycerides Associated With Low-Grade Systemic Inflammation, Adhesion Molecules, and Angiographic Coronary Artery Disease: The Ludwigshafen Risk and Cardiovascular Health Study
Circulation, November 9, 2004; 110(19): 3068 - 3074.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
L. Pavan, A. Hermouet, V. Tsatsaris, P. Therond, T. Sawamura, D. Evain-Brion, and T. Fournier
Lipids from Oxidized Low-Density Lipoprotein Modulate Human Trophoblast Invasion: Involvement of Nuclear Liver X Receptors
Endocrinology, October 1, 2004; 145(10): 4583 - 4591.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
K. Winkler, T. Konrad, S. Fullert, I. Friedrich, R. Destani, M. W. Baumstark, K. Krebs, H. Wieland, and W. Marz
Pioglitazone Reduces Atherogenic Dense LDL Particles in Nondiabetic Patients With Arterial Hypertension: A double-blind, placebo-controlled study
Diabetes Care, September 1, 2003; 26(9): 2588 - 2594.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
V. Vihma, A. Tiitinen, O. Ylikorkala, and M. J. Tikkanen
Quantitative Determination of Estradiol Fatty Acid Esters in Lipoprotein Fractions in Human Blood
J. Clin. Endocrinol. Metab., June 1, 2003; 88(6): 2552 - 2555.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
K. Winkler, B. Wetzka, M. M. Hoffmann, I. Friedrich, M. Kinner, M. W. Baumstark, H.-P. Zahradnik, H. Wieland, and W. Marz
Triglyceride-Rich Lipoproteins Are Associated with Hypertension in Preeclampsia
J. Clin. Endocrinol. Metab., March 1, 2003; 88(3): 1162 - 1166.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
J. Wiemer, K. Winkler, M. Baumstark, W. Marz, and J. E. Scherberich
Influence of low molecular weight heparin compared to conventional heparin for anticoagulation during haemodialysis on low density lipoprotein subclasses
Nephrol. Dial. Transplant., December 1, 2002; 17(12): 2231 - 2238.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
K. Winkler, C. Abletshauser, M. M. Hoffmann, I. Friedrich, M. W. Baumstark, H. Wieland, and W. Marz
Effect of Fluvastatin Slow-Release on Low Density Lipoprotein (LDL) Subfractions in Patients with Type 2 Diabetes Mellitus: Baseline LDL Profile Determines Specific Mode of Action
J. Clin. Endocrinol. Metab., December 1, 2002; 87(12): 5485 - 5490.
[Abstract] [Full Text] [PDF]


Home page
British Journal of Diabetes & Vascular DiseaseHome page
K. Winkler, I. Friedrich, M. W Baumstark, H. Wieland, and W. Marz
Pioglitazone reduces atherogenic dense low density lipoprotein (LDL) particles in patients with type 2 diabetes mellitus
The British Journal of Diabetes & Vascular Disease, March 1, 2002; 2(2): 143 - 148.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2000 by The Endocrine Society